UPMC Cardio-Oncology and Cardiac Imaging Symposium UPMC Cardio-Oncology and Cardiac Imaging Symposium

Presented by: The UPMC Heart and Vascular Institute

Cancer care and treatment have greatly evolved over the past decades. Thanks to teams of devoted researchers, cancer patients are surviving and thriving.

Detailed research has also led to the finding of cardiovascular toxicities from certain cancer treatments, drugs, and radiation therapy.

The UPMC Center for Cardio-Oncology is a partnership between the UPMC Heart and Vascular Institute and UPMC Hillman Cancer Center. We work to prevent, detect, and treat heart and blood vessel problems resulting from cancer treatment.

By teaming up with the experts at UPMC Hillman Cancer Center, the center offers a unique treatment approach that includes:

  • Assessing the risks of heart disease based on cancer type and treatment, family history, and other factors.
  • Using state-of-the-art 2- and 3-D echocardiography (echo), including myocardial strain assessment.
  • Working directly with cancer doctors to design treatment plans that lower the risk of heart disease while effectively treating cancer.

The center is among the first of its kind. It brings together the unique skills of both UPMC cardiologists and oncologists to provide complete care for cancer patients and survivors.

Excellence in Cardio-Oncology and Cardiac Imaging

These CME courses are designed for cardiologists (both invasive and non-invasive), cardiac surgeons, hematologists, oncologists and primary care providers as well as advanced practice providers, nurses, technologists, and other interested health care professionals.

Within these CME courses, UPMC experts present on a wide range of topics in the rising specialties of cardio-oncology and cardiac imaging, within the cardiology and oncology environments, including:

  • Prevention and treatment of cardiovascular complications of cancer-related therapies.
  • Use of non-invasive imaging to prevent and detect cancer therapy-related cardiac dysfunction.
  • Diagnosis and treatment of cardiac amyloidosis, including the use of novel imaging techniques and new therapeutic treatment options.
  • The role of echo in evaluating candidates and guiding therapy for structural heart interventions.
  • Use of microbubble contrast in the echo lab and potential future applications.

These CME courses draw on the expertise of the UPMC Center for Cardio-Oncology and aim to educate and provide knowledge to better care for patients with these conditions.

Physicians may earn a total of 5.75 AMA PRA Category 1 Credits by completing all CME courses.

To speak with a member of our team or to make a referral, call 1-833-UPMC-CCO (876-2226).